{"name":"Vascular Pharmaceuticals, Inc.","slug":"vascular-pharmaceuticals-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxOVDlUaWljUHVZQnpsZFFUNm1RaUxRREFfSmlzdkxRa1gyUkJoVW9HaGo4Z2M5elJIWU9PUzBLazdLRmhCQUJ1WUdQdzFtRDhtbGNKekpydVBaVVl0ZE5TY3BuWkJJV1V1NFNIbGl6bWRMNUs5eDZkUURzbV9vVjdRNFIxVEZTU1NzWGRBSklVQ3l5bTdnUDJPb0lsXzh0S0k?oc=5","date":"2026-03-09","type":"trial","source":"openPR.com","summary":"Vascular Dementia Clinical Trial Pipeline Expands as 11+ Pharma - openPR.com","headline":"Vascular Dementia Clinical Trial Pipeline Expands as 11+ Pharma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxQNHZZaXA1NGRGcXZ5azB4OTNMVW9NVy1RU2Q5REJjcGVwcXhxNFRSa1gxSUppMGM2UGVfcHRxaTYtZDVXdVVtYjlHdEhKdnRBb0NObDdJOHBXaEtiMllaMnlqYnFzSTJkR1ZscW5sdXJnakRjOVc2VmRzaUVtd2xtTm5hRW5Uc0p0U0J4anExekVMczZxR09pTk1Sc1N5LXJIUFFTUTZR?oc=5","date":"2026-03-06","type":"deal","source":"Pharmaceutical Technology","summary":"Alnylam and Tenaya sign $1.23bn cardiovascular target discovery deal - Pharmaceutical Technology","headline":"Alnylam and Tenaya sign $1.23bn cardiovascular target discovery deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxNYzdHZUF4QmhKRHlIRGlTMXZ5cGU5ZUtTUHBoNU9TcDJ1WXJOb1kyQy1zOTgtUjRIWkJiUV9ESDQxYkdLcUhiejVXTmdCTV9hN1A2cmlIcF9GZW14WFlzNlozb3VNZ0xyMzUxN1Jrbk5aRmV4a1VpV25xMHQ4WVduVjc3ZUNWY054VXdkNnhIWF9XNkNfMkEw?oc=5","date":"2026-03-04","type":"deal","source":"Pharmaceutical Technology","summary":"Esperion to acquire Corstasis for cardiovascular franchise expansion - Pharmaceutical Technology","headline":"Esperion to acquire Corstasis for cardiovascular franchise expansion","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi9wFBVV95cUxPWE5PeDl6VGpTS2dfMDZUcVk1STN4LUhpdkJwS19NX0RCamlac2NzbGw5N3hkdTg1Q2xUd1VHLWZTQjdpLXlIdXhycFIycnMwSWxxRXlVcDNMblQtTEVnRjlSXzdvNHVzUThNN3VBMExMRnB0QmlhUmRWSXh0Y1RiZnhka3ZNTmtHekcydVJoSXNGS3EzM2RBNExyRVhuMTh0SzdFc1JGdzBKRVNTNVRnamlTQkYxQXlQOTczUzl3aEZ2WDZ1WUJfZllBb0diSWZmMDJBUFpsdzNIak9UcWRNREYzdll2SjJWT2ZORFBxQkdSWk1tRGww?oc=5","date":"2026-03-03","type":"deal","source":"Citeline News & Insights","summary":"Deal Watch: Esperion Augments Cardiovascular Franchise Via Corstasis Buyout - Citeline News & Insights","headline":"Deal Watch: Esperion Augments Cardiovascular Franchise Via Corstasis Buyout - Citeline News & Insights","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxOT2VJVjdyekswdnA0V2Y4ajFYSXpJQTJRZjc3V3d1dTdaNGxMVDBPT3NiWjJNMEUwTkNLdkV2X1FlelpPUjdWTEhGRzJwdW1VMTYtRUM4MUpsenZKQmlPODF0Z1UxM29xWjhZTXJSRy1najB5Y01uZjZhT0JaVmZPcEF3OElubkUwRU1CVU83Zmc4V2t6dlNVYkRhRQ?oc=5","date":"2026-02-19","type":"earnings","source":"Statista","summary":"Major pharma companies by cardiovascular drug revenue worldwide 2023 and 2030 - Statista","headline":"Major pharma companies by cardiovascular drug revenue worldwide 2023 and 2030","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwJBVV95cUxQajRuYlNnSWN0Z3hxbm5RSjdyczFGSEZ4UTRVUHp1ZnFsSkhOMEo2RVJEbnhQa2RXZ3JlbEdPQTJzVHMzUGxXelhCb2hxTmhKdjdZMkxLOGZYMDRha3lab2djRVg0NWxLMUlkbExBWjlqeHg2VkhuazBibzhaMlkwMllhNjR6RGdrVEdSc1JISVJmLVkzNzRKQmU2UXJuU3ZUZDFOWWJKZGg4Ql9ZNTg0ZVBDRjRzZmdJcFZtWXllZVFuTG9HamVSREZsaTVXci1uOTdjdV9TTkdqSHhPS1cxdFFaaVVZRUFmOXV4Q3JxTUpUTEhfRWhjTjVYaTQ1SDlHQ1oyMTl0ZExFQTh1QnJDMzN6T0hnZmc?oc=5","date":"2026-01-15","type":"deal","source":"businesswire.com","summary":"FillPoint Health and US Heart & Vascular Partner to Expand Access to Innovative Therapies Across Complex Cardiovascular Disease Areas - businesswire.com","headline":"FillPoint Health and US Heart & Vascular Partner to Expand Access to Innovative Therapies Across Complex Cardiovascular ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi-wFBVV95cUxQVXhCMV9MSXN2NVdQVUo1M1VDVnJqWHI4YzNBSzhjN3hlOXZla1M5V1FVd1I5V0lXWExMNzgzdy0xNW5uUXNrVHdLRVlWMk9wOFFnSkpuZ1lnU1NNa212cFl5SVNtaHNheDBaWmZxWnZVOVN5TUNmRXNmQzZkd0ZqbVV0dUtHcExFYXB1QnJzaTNrZ0R1OHZ2TklHX1NqN3lSVTE1T2pxdEppTmdxZW5yNFVPWndYS0JpRk9SX202SG5DNFcwbVJZTEN3ajJsZlV2TFJXbEU1anhURE1TZEQ1TmVpQjdXdDRpT29CVG91RUxKSUxsanNWeEg4NA?oc=5","date":"2025-12-23","type":"pipeline","source":"GlobeNewswire","summary":"Windtree Therapeutics Announces the Sale of its Cardiovascular Biotech Pipeline Drug Candidates - GlobeNewswire","headline":"Windtree Therapeutics Announces the Sale of its Cardiovascular Biotech Pipeline Drug Candidates","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAJBVV95cUxOa1pRMi1EY0ZQTnp0a2hXcFgwRFhLaTB0OHVBb2tTS2dfUUJBekZiTk11b2hmRy16OVhDVnNiamlJNEtxeDVfR0xYOE5QejhTZ0J4NWxMSnNiWFBCWjRIVFZLWkN2UHZ6TEtrOG5adGVUX2RNX3g5aVg4aDhLSmFnNTNGSzhLdUFTMFF0elJReFRpMDM1Ry03MXppVGRXTFlqVFh6Z1VaUkRsaGJQTG5wVXo0R0JPa3VJUEhhREdiang5NXJLaWlKR1ZLSlFMdDlBVk1GYUpOVE00WnY5X2F5M0lLdzJuTlFxSlFrNkZ0NnZFcVcwVkxDQW5OVVlEZ0Jn?oc=5","date":"2025-10-23","type":"deal","source":"businesswire.com","summary":"FillPoint Health, a Lyceum Health Company, Announces Exclusive Specialty Pharmacy Partnership with US Heart & Vascular - businesswire.com","headline":"FillPoint Health, a Lyceum Health Company, Announces Exclusive Specialty Pharmacy Partnership with US Heart & Vascular","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxNZU50WWp1c0VZbS1ndGwtMmVIQUV4U0Y2cmpVaUU4X3F3U0U4Y3dzd2l6UFRkWmRFbGJjdHRDT3hhQU5kQTFsdi1uMWkxT2haRThaRXlfUUkweU9ERDRFMzVOOVFiMFpCc3NFVnpNZU50RGxEcHNHaW5VQnVHSmlSWmFLU1g4T3NQV0gza1BBbXNHcGwzVkNlVFk4N3V5cE5GOTRxT3R4LURRZkE1SnlWVDFjWklhLUh1VzVUdHJRdUdTUQ?oc=5","date":"2025-10-23","type":"trial","source":"MedCity News","summary":"Ventyx Bio Cardiovascular Drug’s Phase 2 Results Set Up Talks With a Big Pharma Firm - MedCity News","headline":"Ventyx Bio Cardiovascular Drug’s Phase 2 Results Set Up Talks With a Big Pharma Firm","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-07-31","type":"pipeline","source":"The Economic Times","summary":"Pharma major Eli Lilly claims its weight loss drug reduces cardiovascular risks in Type 2 diabetes patient - The Economic Times","headline":"Pharma major Eli Lilly claims its weight loss drug reduces cardiovascular risks in Type 2 diabetes patient","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxPWG5nR1hNQTYzVmo1bzZDUzM0LWRqeUZDeTUzVUNGdFE1cmxHOU81bHluNVZ1QTJmcnprSmFmV1ZVU091b3hLQnlQS2xjVm15YU1mamJpbDNwNlpfckpGN0dISTRGQVVfQzhpMTFEUXl2Q0xOSU5tOXREODZ2ZHprWHdFRFhRQ244Z2JhenpQZ05OUVFuMnE0ejNCRTBWengtX1VsaWk1TDFVcUhSdDVJZ2lXYk1nZi1OS3Vjb3diZw?oc=5","date":"2025-06-17","type":"deal","source":"Eli Lilly","summary":"Lilly to acquire Verve Therapeutics to advance one-time treatments for people with high cardiovascular risk - Eli Lilly","headline":"Lilly to acquire Verve Therapeutics to advance one-time treatments for people with high cardiovascular risk","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxOUjJMWFFDU2dHQXVTaGpwNE1zVHNVSWpUelBOLTJyb1NVLVlERGlkNEZKdm1RVWdlbzAxVGxRWHBpVHVVVUdfbHlSNXUxZklZRVFMQlBmTUI4STkzOGtKUUIyQUhkdmFvSWJDYk5mYW5oT21iNUlaTlhoMnI0RXdkZm1odG5iRHlEejFUUnZqTE82Zw?oc=5","date":"2025-06-06","type":"trial","source":"Yahoo Finance","summary":"Rectify Pharma Presents Translational Data Demonstrating Improvements in Kidney Function and Reductions in Vascular Calcification at ERA 2025 - Yahoo Finance","headline":"Rectify Pharma Presents Translational Data Demonstrating Improvements in Kidney Function and Reductions in Vascular Calc","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}